A new immune cell conversion technology has been developed that directly transforms somatic cells into 'Natural Killer (NK) ...
TOKYO and HENNIGSDORF, Germany, Oct. 3, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pantherna ...
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
A new player has entered the hair loss scene promising a new form of treatment that takes a more efficient approach to regenerating lost follicles. Like many solutions in the space, dNovo's technology ...
Asgard Therapeutics AB has raised €30 million (US$32.8 million) in a series A round to advance a novel approach to cancer immunotherapy, in which it is proposed to reprogram cancer cells into ...
Yang Zhou, Ph.D., assistant professor in the Department of Biomedical Engineering, received a Transformational Project Award from the American Heart Association to support her project, “Systematic ...
A stride that marked the turn of the century—realizing the possibility of reprogramming embryonic and adult fibroblasts into pluripotent stem cells by the co-expression of only four gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback